HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Hosoya Selected Research

VAC protocol

11/2013VAC protocol for treatment of dogs with stage III hemangiosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Hosoya Research Topics

Disease

19Neoplasms (Cancer)
04/2022 - 03/2008
6Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 04/2008
3Histiocytic Sarcoma
09/2015 - 01/2013
2Transitional Cell Carcinoma
03/2022 - 04/2015
2Melanoma (Melanoma, Malignant)
01/2022 - 01/2013
2Joint Diseases (Joint Disease)
05/2018 - 06/2012
1Cushing Syndrome
07/2022
1Intussusception
11/2021
1Carcinogenesis
06/2019
1Arthritis (Polyarthritis)
02/2019
1Experimental Arthritis
02/2019
1Urinary Incontinence
01/2019
1Hematuria
01/2019
1Urethral Obstruction
01/2019
1Dysuria
01/2019
1Carcinoma (Carcinomatosis)
01/2019
1Bone Resorption
05/2018
1Bone Diseases (Bone Disease)
05/2018
1Osteoarthritis
05/2018
1Carcinoid Tumor (Carcinoid)
11/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2015
1Cystitis
04/2015
1Seminoma
03/2015
1Hemangiosarcoma (Angiosarcoma)
11/2013
1Hemorrhage
06/2012
1Synovitis
06/2012
1Osteochondrosis (Osgood Schlatter Disease)
02/2010
1Intra-Articular Fractures
02/2010
1Osteoradionecrosis
03/2008
1Lymphoma (Lymphomas)
11/2007

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
09/2015 - 04/2008
3Proteins (Proteins, Gene)FDA Link
04/2022 - 04/2015
3Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2010
3SurvivinIBA
09/2015 - 01/2013
2Messenger RNA (mRNA)IBA
02/2019 - 04/2015
2Collagen Type II (Type II Collagen)IBA
02/2019 - 02/2010
2sepantroniumIBA
09/2015 - 04/2015
2Small Interfering RNA (siRNA)IBA
04/2015 - 01/2013
2Prednisone (Sone)FDA LinkGeneric
01/2009 - 11/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2022
1CreatinineIBA
07/2022
1TOR Serine-Threonine KinasesIBA
04/2022
1MTOR InhibitorsIBA
04/2022
1gedatolisibIBA
04/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1AntibodiesIBA
01/2022
1Metformin (Glucophage)FDA LinkGeneric
09/2021
1Monoclonal AntibodiesIBA
02/2021
1LigandsIBA
02/2021
1toceranib phosphateIBA
07/2020
1Carrier Proteins (Binding Protein)IBA
06/2019
1CytokinesIBA
02/2019
1incomplete Freund's adjuvantIBA
02/2019
1Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link
02/2019
1AcidsIBA
05/2018
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2018
1RANK LigandIBA
05/2018
1Macrophage Colony-Stimulating FactorIBA
05/2018
1Phosphates (Orthophosphate)IBA
05/2018
1tartaric acid (tartrate)FDA Link
05/2018
1Pharmaceutical PreparationsIBA
05/2018
1GastrinsIBA
11/2015
1Chromogranin AIBA
11/2015
1Octreotide (Sandostatin)FDA LinkGeneric
11/2015
1ChromatinIBA
04/2015
1Nuclear Proteins (Protein, Nuclear)IBA
04/2015
1CXC ChemokinesIBA
03/2015
1artemisinin (artemisinine)IBA
11/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014
1Suramin (Suramin Sodium)IBA
01/2014
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2013
1carprofenFDA Link
08/2013
1Meloxicam (Mobic)FDA LinkGeneric
08/2013
1Annexin A5IBA
01/2013
1Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric
06/2012
1tepoxalinIBA
06/2012
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2012
1procollagen type II carboxy-terminal peptideIBA
02/2010
1Lomustine (CCNU)FDA Link
01/2009
1artenimol (dihydroartemisinin)IBA
04/2008
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2007
1Vincristine (Oncovin)FDA LinkGeneric
11/2007

Therapy/Procedure

4Therapeutics
03/2022 - 01/2014
3Drug Therapy (Chemotherapy)
01/2014 - 11/2007
2Transplantation
03/2019 - 04/2015
2Surgical Amputation (Amputations)
01/2014 - 06/2012
1Traction
11/2021
1Immunotherapy
02/2021
1Cell Transplantation
01/2021
1Heterologous Transplantation (Xenotransplantation)
06/2019
1Intradermal Injections
02/2019
1Aftercare (After-Treatment)
01/2019
1Palliative Care (Palliative Therapy)
01/2019
1VAC protocol
11/2013
1Microspheres (Microsphere)
01/2013
1Pain Management
06/2012
1Radiotherapy
03/2008